MPG.eBooks - Author Search Results

Cover Image

201

CADTH Canadian Drug Expert Committee recommendation: Dolutegravir/Rilpivirine (Juluca -- ViiV healthcare) : indication : the treatment of human immunodeficiency virus (HIV-1) infec...

Published 2018

CADTH

“...CADTH Canadian Drug Expert Committee...”

Cover Image

202

CADTH Canadian drug expert committee recommendation: Siponimod (Mayzent -- Novartis Pharmaceuticals Canada Inc.) : indication : secondary progressive multiple sclerosis

Published 2020

Canadian Agency for Drugs and Technologies in Health

“...CADTH Canadian Drug Expert Committee...”

Cover Image

203

CADTH Canadian drug expert committee recommendation: Cysteamine ophthalmic solution (Cystadrops -- recordati rare diseases Canada Inc.) : indication : treatment of corneal cystine...

Published 2019

Canadian Agency for Drugs and Technologies in Health

“...CADTH Canadian Drug Expert Committee...”

Cover Image

204

CADTH Canadian Drug Expert Committee recommendation: Brolucizumab (Beovu -- Novartis Pharmaceuticals Canada Inc.) : indication : treatment of neovascular (wet) age-related macular...

Published 2020

Canadian Agency for Drugs and Technologies in Health

“...CADTH Canadian Drug Expert Committee...”

Cover Image

205

CADTH Canadian Drug Expert Committee final recommendation: Ticagrelor (Brilinta -- AstraZeneca Canada Inc.) indication : secondary prevention of atherothrombotic events

Published 2016

Canadian Agency for Drugs and Technologies in Health

“...CADTH Canadian Drug Expert Committee...”

Cover Image

206

CADTH Canadian Drug Expert Committee final recommendation: Canagliflozin and metformin hydrochloride (Invokamet -- Janssen Inc.) : type 2 diabetes mellitus

Published 2016

Canadian Agency for Drugs and Technologies in Health

“...CADTH Canadian Drug Expert Committee...”

Cover Image

207

CADTH Canadian Drug Expert Committee recommendation (final): Letermovir (Prevymis -- Merck Canada Inc.) indication : cytomegalovirus infection, prophylaxis

Published 2018

CADTH

“...CADTH Canadian Drug Expert Committee...”

Cover Image

208

CADTH Canadian Drug Expert Committee final recommendation: Dapagliflozin (Forxiga -- AstraZeneca Canada Inc.) indication : type 2 diabetes

Published 2016

Canadian Agency for Drugs and Technologies in Health

“...CADTH Canadian Drug Expert Committee...”

Cover Image

209

CADTH Canadian Drug Expert Committee recommendation: Dexamethasone (Ozurdex -- Allergan Canada Inc.) indication: for the treatment of adult patients with diabetic macular edema who...

Published 2018

CADTH

“...CADTH Canadian Drug Expert Committee...”

Cover Image

210

CADTH Canadian Drug Expert Review Committee final recommendation: Riociguat (Adempas - Bayer HealthCare Inc.) : indication: pulmonary arterial hypertension

Published 2015

Canadian Agency for Drugs and Technologies in Health

“...CADTH Canadian Drug Expert Committee...”

Cover Image

211

CADTH Canadian Drug Expert Committee recommendation: AbobotulinumtoxinA (Dysport therapeutic--Ipsen Biopharmaceuticals Canada, Inc.) : indication to reduce the subjective symptoms...

Published 2017

Canadian Agency for Drugs and Technologies in Health

“...CADTH Canadian Drug Expert Committee...”

Cover Image

212

CADTH Canadian Drug Expert Committee final recommendation: Tesamorelin (Egrifta -- Theratechnologies Inc.) indication : HIV-associated lipohypertherapy

Published 2016

Canadian Agency for Drugs and Technologies in Health

“...CADTH Canadian Drug Expert Committee...”

Cover Image

213

CADTH Canadian Drug Expert Committee recommendation: Nitisinone (Orfadin -- Sobi Canada Inc.) : indication: the treatment of adult and pediatric patients with hereditary tyrosinemi...

Published 2018

CADTH

“...CADTH Canadian Drug Expert Committee...”

Cover Image

214

CADTH Canadian Drug Expert Committee recommendation: Sofosbuvir/Velpatasvir/Voxilaprevir (Vosevi -- Gilead Sciences Canada, Inc.) : indication : chronic hepatitis C virus infection

Published 2018

CADTH

“...CADTH Canadian Drug Expert Committee...”

1
2
3
4
5
6
7
8
9
10
11